Viridian Therapeutics, Inc.\DE (NASDAQ:VRDN) appears in 225 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,003,402 | 18.48% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 2,135,101 | 17.43% | $0.00 |
| Bellevue Group AG | 31 Dec, 2025 | 0 | 4,358,527 | 0.00% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 3,000,000 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,280,161 | 29.55% | $0.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 0 | 454,545 | 13.14% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -89,370 | -26.79% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 912,394 | 35.72% | $0.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,286 | 126.08% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 1,580,303 | 108.06% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | -2,855,616 | -53.07% | $0.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | -142,071 | -7.38% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 225,987 | 12.80% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 227,272 | 13.03% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -2,957,386 | -66.79% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 848,879 | 75.62% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | -1,166,251 | -44.70% | $0.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -1,050,299 | -36.94% | $0.00 |